There is that chance, as well as FIRB not approving the TO. I see merit in a further offer being made once SXY have released next quarterly. That's what I'm hanging in for.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%